Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Non-Current Debt: 2017-2021

Historic Non-Current Debt for Sunshine Biopharma (SBFM) over the last 4 years, with Dec 2021 value amounting to $1.9 million.

  • Sunshine Biopharma's Non-Current Debt rose 100.21% to $1.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.9 million, marking a year-over-year increase of 100.21%. This contributed to the annual value of $1.9 million for FY2021, which is 100.21% up from last year.
  • According to the latest figures from FY2021, Sunshine Biopharma's Non-Current Debt is $1.9 million, which was up 100.21% from $949,006 recorded in FY2020.
  • In the past 5 years, Sunshine Biopharma's Non-Current Debt registered a high of $1.9 million during FY2021, and its lowest value of $79,710 during FY2017.
  • In the last 2 years, Sunshine Biopharma's Non-Current Debt had a median value of $1.4 million in 2020 and averaged $1.4 million.
  • Data for Sunshine Biopharma's Non-Current Debt shows a peak YoY soared of 263.63% (in 2018) over the last 5 years.
  • Over the past 4 years, Sunshine Biopharma's Non-Current Debt (Yearly) stood at $79,710 in 2017, then skyrocketed by 263.63% to $289,847 in 2018, then reached $949,006 in 2020, then skyrocketed by 100.21% to $1.9 million in 2021.